Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Biedermann

Showing results (181-190 of 201) with videos related to

Pageof 21
Sort By:
BMJ Open|January 7, 2017
Protocol for a prospective, controlled, observational study to evaluate the influence of hypoxia on healthy volunteers and patients with inflammatory bowel disease: the Altitude IBD StudyStephan Vavricka, Pedro A Ruiz, Sylvie Scharl, et al.
Allergy|January 30, 2022
Characterization of eosinophilic esophagitis variants by clinical, histological, and molecular analyses: A cross-sectional multi-center studyThomas Greuter, Alex Straumann, Yuniel Fernandez-Marrero, et al.
Gastroenterology|July 30, 2020
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic EsophagitisAlex Straumann, Alfredo J Lucendo, Stephan Miehlke, et al.
Allergy|July 15, 2020
Food-induced immediate response of the esophagus-A newly identified syndrome in patients with eosinophilic esophagitisLuc Biedermann, Mark Holbreich, Dan Atkins, et al.
Clinical and Translational Gastroenterology|February 6, 2024
A Multicenter Long-Term Cohort Study of Eosinophilic Esophagitis Variants and Their Progression to Eosinophilic Esophagitis Over TimeThomas Greuter, Alex Straumann, Yuniel Fernandez-Marrero, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2024
Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: An Open-Label Extension StudyLuc Biedermann, Christoph Schlag, Alex Straumann, et al.
Inflammatory Intestinal Diseases|July 19, 2018
Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)Ekaterina Safroneeva, Catherine Saner, Jean-Benoît Rossel, et al.
Inflammatory Bowel Diseases|September 16, 2024
Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative ColitisDavid T Rubin, Olga Kubassova, Christopher R Weber, et al.
United European Gastroenterology Journal|July 2, 2026
Global Roll-Out and Continued Multi-Site Validation of the Artificial Intelligence Histology Instrument for Qualitative Assessment of Histopathology in Ulcerative ColitisLaurent Peyrin-Biroulet, Olga Kubassova, Jon Himoff, et al.
Inflammatory Bowel Diseases|April 29, 2017
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort StudyStephan R Vavricka, Martin Gubler, Claudine Gantenbein, et al.
Pageof 21

Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
BMJ Open|January 7, 2017
Protocol for a prospective, controlled, observational study to evaluate the influence of hypoxia on healthy volunteers and patients with inflammatory bowel disease: the Altitude IBD StudyStephan Vavricka, Pedro A Ruiz, Sylvie Scharl, et al.
Allergy|January 30, 2022
Characterization of eosinophilic esophagitis variants by clinical, histological, and molecular analyses: A cross-sectional multi-center studyThomas Greuter, Alex Straumann, Yuniel Fernandez-Marrero, et al.
Gastroenterology|July 30, 2020
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic EsophagitisAlex Straumann, Alfredo J Lucendo, Stephan Miehlke, et al.
Allergy|July 15, 2020
Food-induced immediate response of the esophagus-A newly identified syndrome in patients with eosinophilic esophagitisLuc Biedermann, Mark Holbreich, Dan Atkins, et al.
Clinical and Translational Gastroenterology|February 6, 2024
A Multicenter Long-Term Cohort Study of Eosinophilic Esophagitis Variants and Their Progression to Eosinophilic Esophagitis Over TimeThomas Greuter, Alex Straumann, Yuniel Fernandez-Marrero, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2024
Efficacy and Safety of Budesonide Orodispersible Tablets for Eosinophilic Esophagitis up to 3 Years: An Open-Label Extension StudyLuc Biedermann, Christoph Schlag, Alex Straumann, et al.
Inflammatory Intestinal Diseases|July 19, 2018
Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS)Ekaterina Safroneeva, Catherine Saner, Jean-Benoît Rossel, et al.
Inflammatory Bowel Diseases|September 16, 2024
Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative ColitisDavid T Rubin, Olga Kubassova, Christopher R Weber, et al.
United European Gastroenterology Journal|July 2, 2026
Global Roll-Out and Continued Multi-Site Validation of the Artificial Intelligence Histology Instrument for Qualitative Assessment of Histopathology in Ulcerative ColitisLaurent Peyrin-Biroulet, Olga Kubassova, Jon Himoff, et al.
Inflammatory Bowel Diseases|April 29, 2017
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort StudyStephan R Vavricka, Martin Gubler, Claudine Gantenbein, et al.
Pageof 21